Becton Dickinson Company Overview

What is the Stock Ticker for Becton Dickinson?

The stock ticker for Becton Dickinson is BDX.

Where is the Becton Dickinson headquarters?

Becton Dickinson's headquarters is located in Franklin Lakes, New Jersey, United States.

What Does Becton Dickinson Do?

Becton Dickinson is a global medical technology company that develops and manufactures medical devices, instrument systems, and reagents. Their products are used in healthcare settings to improve patient care and outcomes, including diagnostics, medication management, and infection prevention.

How Does Becton Dickinson Make Money?

Becton Dickinson (BD) is a global medical technology company that primarily makes money by selling medical devices, instruments, and reagents to healthcare institutions, laboratories, and clinics. The company operates in three main segments: BD Medical, BD Life Sciences, and BD Interventional.

BD Medical segment offers a wide range of medical devices and products such as syringes, needles, infusion sets, catheters, and insulin delivery systems. The segment also provides diagnostic systems, software, and services for medication management and infection prevention. BD Medical generates revenue by selling these products and services to hospitals, clinics, and other healthcare providers.

BD Life Sciences segment provides products and services for research laboratories, pharmaceutical companies, and clinical laboratories. The segment offers a range of instruments, reagents, and assays for cell analysis, genomics, and microbiology. BD Life Sciences generates revenue by selling these products and services to research institutions, pharmaceutical companies, and clinical laboratories.

BD Interventional segment provides medical devices and products for interventional procedures such as vascular access, peripheral intervention, and urology. The segment offers products such as catheters, stents, and balloons. BD Interventional generates revenue by selling these products to hospitals, clinics, and other healthcare providers.

In addition to these segments, BD also generates revenue through its global services division, which provides technical support, training, and consulting services to its customers.

Overall, Becton Dickinson makes money by selling medical devices, instruments, and reagents to healthcare institutions, laboratories, and clinics. The company's revenue comes from the sale of these products and services to its customers.

Who Founded Becton Dickinson?

Becton Dickinson was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897.

What is the History of Becton Dickinson?

Becton Dickinson (BD) is a global medical technology company that was founded in 1897 by Maxwell Becton and Fairleigh Dickinson. The company started as a manufacturer of surgical needles and syringes, and over the years, it expanded its product portfolio to include a wide range of medical devices and diagnostic solutions.

In the early 20th century, BD became a leading supplier of medical equipment to the US military during World War I and II. In the 1950s, the company introduced the first plastic syringe, which revolutionized the medical industry and became a standard in healthcare.

Throughout the 1960s and 1970s, BD continued to expand its product offerings, acquiring several companies and developing new technologies. In 1974, the company introduced the first automated blood culture system, which helped to improve the accuracy and speed of diagnosing infections.

In the 1990s, BD expanded its global presence, establishing operations in Europe, Asia, and Latin America. The company also continued to innovate, introducing new products such as the first safety-engineered needle in 1992.

Today, BD is a leading provider of medical technology solutions, with a portfolio that includes products for medication management, infection prevention, diagnostic testing, and more. The company operates in over 190 countries and employs more than 70,000 people worldwide.

What Industry is Becton Dickinson In?

Becton Dickinson is in the medical technology and devices industry.

What Are Becton Dickinson's Competitive Advantages?

Becton Dickinson has several competitive advantages that set it apart from its competitors. Some of these advantages include:

1. Strong brand recognition: Becton Dickinson is a well-known and respected brand in the healthcare industry. Its products are trusted by healthcare professionals around the world, which gives the company a competitive edge.

2. Diversified product portfolio: Becton Dickinson offers a wide range of products, including medical devices, diagnostic systems, and laboratory equipment. This diversification helps the company to mitigate risks and capture opportunities in different markets.

3. Strong distribution network: Becton Dickinson has a strong distribution network that allows it to reach customers in different regions of the world. This network helps the company to quickly respond to customer needs and stay ahead of its competitors.

4. Focus on innovation: Becton Dickinson invests heavily in research and development to create innovative products that meet the evolving needs of the healthcare industry. This focus on innovation helps the company to stay ahead of its competitors and maintain its market leadership.

5. Strong financial position: Becton Dickinson has a strong financial position, with a solid balance sheet and a history of consistent profitability. This financial strength gives the company the resources it needs to invest in growth opportunities and weather economic downturns.

What Are Becton Dickinson's Competitive Threats?

Some potential competitive threats to Becton Dickinson could include:

1. Other medical device companies: There are many other companies that produce medical devices, such as Johnson & Johnson, Medtronic, and Abbott Laboratories. These companies may offer similar products to Becton Dickinson, and may have larger market shares or more established brand recognition.

2. Generic manufacturers: Some of Becton Dickinson's products may be subject to competition from generic manufacturers, who can produce similar products at a lower cost.

3. New entrants: There is always the possibility of new companies entering the medical device market, which could disrupt Becton Dickinson's market share and force the company to adapt to new competition.

4. Regulatory changes: Changes in regulations or policies related to healthcare or medical devices could impact Becton Dickinson's ability to operate or sell its products.

5. Economic factors: Economic downturns or changes in healthcare spending could impact demand for Becton Dickinson's products, or make it more difficult for the company to compete with other manufacturers.

Who Are Some of the Competitors of Becton Dickinson?

Some of the competitors of Becton Dickinson include Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Danaher Corporation.

What Are Some of Becton Dickinson's Products and Services?

Some notable products and services from Becton Dickinson include medical devices and diagnostic systems for diabetes care, medication management, infectious diseases, cancer diagnosis and treatment, and surgical procedures. They also offer laboratory equipment and supplies, as well as software solutions for healthcare providers.

Has Becton Dickinson Acquired any Companies?

Yes, Becton Dickinson has made several notable acquisitions, including C.R. Bard Inc. in 2017 for $24 billion, CareFusion Corporation in 2015 for $12.2 billion, and GeneOhm Sciences in 2006 for $230 million.